New from CDC
The Right To Know Campaign Breast Cancer Screening
Breast cancer is the most common cancer in women. And living with a disability does not make you immune. During Breast Cancer Awareness Month in October, learn the facts about breast cancer and why screening should be a regular part of your health care.
Infants with Congenital Disorders Identified Through Newborn Screening — United States, 2015–2017
Newborn screening identifies infants at risk for congenital disorders for which early intervention has been shown to improve outcomes. State public health programs are encouraged to screen for disorders on the national Recommended Uniform Screening Panel, which increased from 29 disorders in 2005 to 35 in 2018.
Antidepressant Use Among Adults: United States, 2015-2018
In 2018, an estimated 7.2% of American adults had a major depressive episode in the past year. Depression is associated with diminished quality of life and increased disability. Antidepressants are one of the primary treatments for depression and are among the most used therapeutic medications in the United States. During 2015–2018, 13.2% of adults aged 18 and over used antidepressant medications in the past 30 days. Use was higher among women (17.7%) than men (8.4%).
COVID-19's Impact on Women
Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020
Pregnant women might be at increased risk for severe coronavirus disease 2019 (COVID-19). The COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) collects data on hospitalized pregnant women with laboratory-confirmed SARS-CoV-2, the virus that causes COVID-19.
SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics — Eight U.S. Health Care Centers, March 1–May 30, 2020
Information about SARS-CoV-2 infection during pregnancy is rapidly growing; however, data on reasons for hospital admission, pregnancy-specific characteristics, and birth outcomes among pregnant women hospitalized with SARS-CoV-2 infections are limited. During March 1–May 30, 2020, as part of Vaccine Safety Datalink (VSD)† surveillance of COVID-19 hospitalizations, 105 hospitalized pregnant women with SARS-CoV-2 infection were identified.
CDC is collaborating with state, local, and territorial health departments and external partners to better understand COVID-19 during pregnancy. Health departments that are notified of COVID-19 cases in pregnant women may collect more information on these women using an optional module in addition to the case report form. Findings will be rapidly translated into updated clinical guidance for pregnant women and infants.
Based on what is known at this time, pregnant women might be at an increased risk for severe illness from COVID-19 compared to non-pregnant women. Additionally, pregnant women with COVID-19 might have an increased risk of adverse pregnancy outcomes, such as preterm birth.
Snapshots
